Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: TSPO in a murine model of Sandhoff disease: presymptomatic marker of neurodegeneration and disease pathophysiology.

Authors: Loth, Meredith K; Choi, Judy; McGlothan, Jennifer L; Pletnikov, Mikhail V; Pomper, Martin G; Guilarte, Tomás R

Published In Neurobiol Dis, (2016 Jan)

Abstract: Translocator protein (18 kDa), formerly known as the peripheral benzodiazepine receptor (PBR), has been extensively used as a biomarker of active brain disease and neuroinflammation. TSPO expression increases dramatically in glial cells, particularly in microglia and astrocytes, as a result of brain injury, and this phenomenon is a component of the hallmark response of the brain to injury. In this study, we used a mouse model of Sandhoff disease (SD) to assess the longitudinal expression of TSPO as a function of disease progression and its relationship to behavioral and neuropathological endpoints. Focusing on the presymptomatic period of the disease, we used ex vivo [(3)H]DPA-713 quantitative autoradiography and in vivo [(125)I]IodoDPA-713 small animal SPECT imaging to show that brain TSPO levels markedly increase prior to physical and behavioral manifestation of disease. We further show that TSPO upregulation coincides with early neuronal GM2 ganglioside aggregation and is associated with ongoing neurodegeneration and activation of both microglia and astrocytes. In brain regions with increased TSPO levels, there is a differential pattern of glial cell activation with astrocytes being activated earlier than microglia during the progression of disease. Immunofluorescent confocal imaging confirmed that TSPO colocalizes with both microglia and astrocyte markers, but the glial source of the TSPO response differs by brain region and age in SD mice. Notably, TSPO colocalization with the astrocyte marker GFAP was greater than with the microglia marker, Mac-1. Taken together, our findings have significant implications for understanding TSPO glial cell biology and for detecting neurodegeneration prior to clinical expression of disease.

PubMed ID: 26545928 Exiting the NIEHS site

MeSH Terms: Aging/metabolism; Aging/pathology; Animals; Astrocytes/metabolism; Astrocytes/pathology; Biomarkers/metabolism; Brain/diagnostic imaging; Brain/metabolism*; Brain/pathology; Disease Models, Animal; Disease Progression; Gangliosidoses, GM2/metabolism; Longitudinal Studies; Mice, Knockout; Microglia/metabolism; Microglia/pathology; Motor Activity/physiology; Nerve Degeneration/diagnostic imaging; Nerve Degeneration/metabolism; Nerve Degeneration/pathology; Prodromal Symptoms; Receptors, GABA/metabolism*; Sandhoff Disease/diagnostic imaging; Sandhoff Disease/metabolism*; Sandhoff Disease/pathology; Tomography, Emission-Computed, Single-Photon

Back
to Top